Lv3
330 积分 2025-09-10 加入
Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety
2天前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
13天前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
13天前
已完结
Third-generation CD19.CAR-T cell-containing combination therapy in Scl70+ systemic sclerosis
13天前
已完结
Efficacy of programmed cell death 1 inhibitor maintenance after chimeric antigen receptor T cells in patients with relapsed/refractory B-cell non-Hodgkin-lymphoma
1个月前
已完结
GPRC5D-targeted CAR T-cell therapy (CT071) in patients with relapsed or refractory multiple myeloma: a first-in-human, single-centre, single-arm, phase 1 trial
1个月前
已完结
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
1个月前
已完结
GD2-targeting CART cellsin high-risk neuroblastoma:a phase 1/2 trial
3个月前
已完结
皖公网安备34019202002308
